Streptococcal Pharyngitis
📧 Sign up to get email alerts when something new happens for Streptococcal Pharyngitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-09-22FDA Approved: CEPHALEXIN — Supplemental Application (AMELLA PHARMA, LLC)
FDA approved a supplemental application for Cephalexin from Amella Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2008-03-26Clinical Trial Update: Multicenter, Open, Randomized Comparative Trial To Compare The Efficacy Of Azithromycin Versus Amoxicillin In Children With Strep Throat [Phase 4]
A multicenter, open-label Phase 4 randomized trial compares azithromycin with amoxicillin in children with strep throat and has completed.
-
CLINICAL_TRIALS trial_result · 2008-01-25Clinical Trial Update: Incidence of Group A Strep Pharyngitis in School Children in Fiji
Completed trial update on the incidence of Group A Streptococcal pharyngitis among school children in Fiji.
-
FDA approval · 2007-09-27FDA Approved: CEPHALEXIN — Supplemental Application (AVKARE)
FDA approved a supplemental application for Cephalexin submitted by AVKARE, indicating an approved modification to this product's label or a…
-
FDA approval · 2007-09-27FDA Approved: CEPHALEXIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Cephalexin from Teva Pharmaceuticals USA, Inc., representing an approved modification to the exi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2006-10-25Clinical Trial Update: APC-111 MP Tablet Once a Day vs.Penicillin VK Four Times a Day Both for 10 Days in Patients With Strep Throat [Phase 3]
Phase 3 trial comparing APC-111 MP Tablet once daily versus Penicillin VK four times daily for 10 days in patients with streptococcal pharyn…
-
CLINICAL_TRIALS trial_result · 2006-10-25Clinical Trial Update: APC-231 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) in Pediatric Patients With Strep Throat [Phase 3]
The document reports the completion of a Phase 3 study comparing APC-231 given once daily for 7 days versus penicillin given four times dail…